Comparison of Fibrinolytic Parameters for Each Treatment Group
| . | Sal/Sal . | tPA/Sal . | Sal/PTI . | tPA/PTI . |
|---|---|---|---|---|
| CL | 38.7 ± 3.6 | 53.5 ± 13.3 | 43.5 ± 7.0 | 89.3 ± 4.9* |
| 125I-FDP | 2.4 ± 1.8 | 10.5 ± 10.6 | 0.9 ± 1.1 | 18.1 ± 13.8 |
| PCCW | 49.7 ± 15.2 | 21.1 ± 21.9 | 54.7 ± 10.8 | −47.4 ± 22.8* |
| NCA | 88.4 ± 14.8 | 74.5 ± 15.0 | 98.3 ± 10.9 | 41.9 ± 18.7 |
| TTP | ≥60.0 | 22.9 ± 5.3 | ≥60.0 | 6.8 ± 2.7* |
| CAP | 0 | 11.0 ± 3.1 | 0 | 30.0 ± 21.8 |
| MF | 0 | 0.9 ± 0.35 | 0 | 1.9 ± 0.39* |
| . | Sal/Sal . | tPA/Sal . | Sal/PTI . | tPA/PTI . |
|---|---|---|---|---|
| CL | 38.7 ± 3.6 | 53.5 ± 13.3 | 43.5 ± 7.0 | 89.3 ± 4.9* |
| 125I-FDP | 2.4 ± 1.8 | 10.5 ± 10.6 | 0.9 ± 1.1 | 18.1 ± 13.8 |
| PCCW | 49.7 ± 15.2 | 21.1 ± 21.9 | 54.7 ± 10.8 | −47.4 ± 22.8* |
| NCA | 88.4 ± 14.8 | 74.5 ± 15.0 | 98.3 ± 10.9 | 41.9 ± 18.7 |
| TTP | ≥60.0 | 22.9 ± 5.3 | ≥60.0 | 6.8 ± 2.7* |
| CAP | 0 | 11.0 ± 3.1 | 0 | 30.0 ± 21.8 |
| MF | 0 | 0.9 ± 0.35 | 0 | 1.9 ± 0.39* |
Parameters determined include: percentage of clot lysis (CL), percentage change in clot weight (PCCW), net clot accreted in percentage (NCA), time to aortic patency in minutes (TTP), cumulative aortic patency during 60 minutes of treatment in percentage (CAP), and maximal blood flow in milliliters per minute (MF). Values are expressed as the mean ± standard error of the mean. Significance was assigned at P < .03.
Compared with treatment with tPA/saline.